- 3 days & nights inpatient stay
- 9 quick follow-up appointments
Participants in this research are reimbursed $3,660 for their time and this clinical trial has been approved by an independent ethics committee.
About the study
This study is looking at a medication for the treatment for migraines, a form of headache which is normally experienced as a one-sided throbbing or pulsing head discomfort. Migraines are one of the most prevalent neurological diseases for which medical treatment is sought and is a leading cause of disability for people under 50. This medication is designed to help prevent migraines from occurring.
How do I find out more?
If you have already registered with us but would like more information about this study, please call 1800 243 733 or schedule a call back. You can also email us at email@example.com quoting “Migraine Prevention Study”.
If you are interested in participating and have not previously registered as a participant with us, fill in your details in the form below and we’ll be in touch soon!